Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Dose”

3,638 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,638 results

Early research (Phase 1)Study completedNCT03273192
What this trial is testing

CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects

Who this might be right for
BioequivalencePhase 1
Cinnagen 74
Early research (Phase 1)Study completedNCT04163107
What this trial is testing

Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Norwegian University of Science and Technology 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400
What this trial is testing

Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Who this might be right for
Breast CancerSolid Tumors
Pfizer 235
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Early research (Phase 1)Study completedNCT01058707
What this trial is testing

Dose Escalation Study of MLN0128 in Participants With Advanced Malignancies

Who this might be right for
Advanced Solid Malignancies
Millennium Pharmaceuticals, Inc. 198
Post-approval studies (Phase 4)Study completedNCT04605107
What this trial is testing

Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA).

Who this might be right for
Infertility, Female
Genuine Research Center, Egypt 60
Early research (Phase 1)Study completedNCT01831700
What this trial is testing

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions

Who this might be right for
Fasting
IPCA Laboratories Ltd. 48
Not applicableUnknownNCT01068067
What this trial is testing

Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Sun Yat-sen University 60
Early research (Phase 1)Study completedNCT02564900
What this trial is testing

Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Advanced Solid Tumors
Daiichi Sankyo Co., Ltd. 292
Early research (Phase 1)Ended earlyNCT01021176
What this trial is testing

Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell

Who this might be right for
Food Intake
Pennington Biomedical Research Center 12
Testing effectiveness (Phase 2)Study completedNCT02336815
What this trial is testing

Selinexor Treatment of Refractory Myeloma

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc 202
Early research (Phase 1)Looking for participantsNCT07372625
What this trial is testing

Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

Who this might be right for
TP53 Y220C MutationAdvanced Solid Tumors
PMV Pharmaceuticals, Inc 14
Early research (Phase 1)Study completedNCT01651325
What this trial is testing

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects

Who this might be right for
Pharmacokinetics of IsavuconazolePharmacokinetics of DextromethorphanHealthy Adult Volunteers
Astellas Pharma Global Development, Inc. 24
Early research (Phase 1)Study completedNCT02382640
What this trial is testing

Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule

Who this might be right for
Healthy Volunteers
Takeda 36
Not applicableNot Yet RecruitingNCT06897189
What this trial is testing

Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thoracic Radiotherapy: A Prospective Cohort Study

Who this might be right for
CardiotoxicityThoracic RadiotherapyWearable Electronic Devices+2 more
Yonsei University 111
Early research (Phase 1)Study completedNCT02195635
What this trial is testing

Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects

Who this might be right for
Drug Interactions
Lexicon Pharmaceuticals 24
Early research (Phase 1)Study completedNCT00836576
What this trial is testing

Benazepril HCl 40 mg Tablets, Fasting

Who this might be right for
Healthy
Teva Pharmaceuticals USA 40
Early research (Phase 1)Looking for participantsNCT07755397
What this trial is testing

First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor

Who this might be right for
NSCLC Patients With EGFR Activating MutationAdenoid Cystic Carcinoma MetastaticAdenoid Cystic Carcinoma of the Head and Neck
Jubilant Therapeutics India Limited 30
Early research (Phase 1)Study completedNCT01056874
What this trial is testing

Effect Of Maraviroc On The Pharmacokinetics Of Digoxin

Who this might be right for
HealthyHIV Infections
ViiV Healthcare 12
Testing effectiveness (Phase 2)Study completedNCT02257918
What this trial is testing

Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea

Who this might be right for
Gonorrhoea
National Institute of Allergy and Infectious Diseases (NIAID) 180
Next Page